| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 30-Sep-08 | | Total Revenue | 2,889 | 3,318 | 3,742 | 3,053 | | Cost of Revenue | 2,424 | 2,530 | 3,004 | 2,740 | | | Gross Profit | 465 | 788 | 738 | 313 | | | Operating Expenses | | Research Development | 897 | 786 | 668 | 1,514 | | Selling General and Administrative | 2,707 | 2,482 | 2,533 | 2,934 | | Non Recurring |
-
|
-
| 140 | 189 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,139) | (2,480) | (2,603) | (4,323) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7) | 50 | 75 | 1,852 | | Earnings Before Interest And Taxes | (3,118) | (2,458) | (2,508) | (2,471) | | Interest Expense | 46 |
-
| 0 | 2 | | Income Before Tax | (3,164) | (2,458) | (2,508) | (2,473) | | Income Tax Expense | 6 | 10 | 2 | (0) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,170) | (2,468) | (2,529) | (2,473) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (17) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,170) | (2,468) | (2,546) | (2,473) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,170) | ($2,468) | ($2,546) | ($2,473) |
|
0.41% Nasdaq 
Income Statement
